Mark Donnelly

Mark Donnelly

Auto-generated profile, based on publicly available information

Mark Donnelly

Department of Surgery, St Vincent’s University Hospital , Dublin , Ireland

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2023 in British Journal of Surgery
Verified
Journal Article
Closed access
PDF file
MDMark Donnelly
Mark Donnelly
OROdhrán K Ryan
Odhrán K Ryan
ERElizabeth Ryan
Elizabeth Ryan
BCBen Creavin
Ben Creavin
MOMary O’reilly
Mary O’reilly
DWDes C Winter
Des C Winter
Background: This study compared the advantages and disadvantages of total neoadjuvant therapy (TNT) strategies for patients with locally advanced rectal cancer, compared with the more traditional multimodal neoadjuvant management strategies of long-course chemoradiotherapy (LCRT) or short-course radiotherapy (SCRT). Methods: A systematic review and network meta-analysis of exclusively RCTs was undertaken, comparing survival, recurrence, pathological, radiological, and oncological outcomes. The last date of the search was 14 December 2022. Results: In total, 15 RCTs involving 4602 patients with locally advanced rectal cancer, conducted between 2004 and 2022, were included. TNT improved overall survival compared with LCRT (HR 0.73, 95 per cent credible interval 0.60 to 0.92) and SCRT (HR 0.67, 0.47 to 0.95). TNT also improved rates of distant metastasis compared with LCRT (HR 0.81, 0.69 to 0.97). Reduced overall recurrence was observed for TNT compared with LCRT (HR 0.87, 0.76 to 0.99). TNT showed an improved pCR compared with both LCRT (risk ratio (RR) 1.60, 1.36 to 1.90) and SCRT (RR 11.32, 5.00 to 30.73). TNT also showed an improvement in cCR compared with LCRT (RR 1.68, 1.08 to 2.64). There was no difference between treatments in disease-free survival, local recurrence, R0 resection, treatment toxicity or treatment compliance. Conclusion: This study provides further evidence that TNT has improved survival and recurrence benefits compared with current standards of care, and may increase the number of patients suitable for organ preservation, without negatively influencing treatment toxicity or compliance.

15 April 2023 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
OROdhrán K. Ryan
Odhrán K. Ryan
KDKatie L. Doogan
Katie L. Doogan
ERElizabeth Ryan
Elizabeth Ryan
MDMark Donnelly
Mark Donnelly
Ian ReynoldsIan Reynolds
Ian Reynolds
DWDes C. Winter
Des C. Winter

20 October 2023 in Inflammatory Bowel Diseases
Verified
Journal Article
Open access
PDF file
MDMark Donnelly
Mark Donnelly
DDDorothee Driever
Dorothee Driever
ERElizabeth Ryan
Elizabeth Ryan
JEJessie A Elliott
Jessie A Elliott
JFJohn Finnegan
John Finnegan
JOJames M O’rIordan
James M O’rIordan
Background: Obesity, sarcopenia, and myosteatosis in inflammatory bowel disease may confer negative outcomes, but their prevalence and impact among patients with Crohn’s disease (CD) have not been systematically studied. The aim of this study was to assess nutritional status and body composition among patients undergoing resectional surgery for CD and determine impact on operative outcomes. Methods: Consecutive patients with CD undergoing resection from 2000 to 2018 were studied. Total, subcutaneous, and visceral fat areas and lean tissue area (LTA) and intramuscular adipose tissue (IMAT) were determined preoperatively by computed tomography at L3 using SliceOmatic (Tomovision, Canada). Univariable and multivariable linear, logistic, and Cox proportional hazards regression were performed. Results: One hundred twenty-four consecutive patients were studied (ileocolonic disease 53%, n = 62, biologic therapy 34.4% n = 43). Mean fat mass was 22.7 kg, with visceral obesity evident in 23.9% (n = 27). Increased fat stores were associated with reduced risk of emergency presentation but increased corticosteroid use (β 9.09, standard error 3.49; P = .011). Mean LBM was 9.9 kg. Sarcopenia and myosteatosis were associated with impaired baseline nutritional markers. Myosteatosis markers IMAT (P = .002) and muscle attenuation (P = .0003) were associated with increased grade of complication. On multivariable analysis, IMAT was independently associated with increased postoperative morbidity (odds ratio [OR], 1.08; 95% confidence interval (CI), 1.01-1.16; P = .037) and comprehensive complications index (P = .029). Measures of adiposity were not associated with overall morbidity; however, increased visceral fat area independently predicted venous thromboembolism (OR, 1.02; 95% CI, 1.00-1.05; P = .028), and TFA was associated with increased wound infection (OR, 1.00; 95% CI, 1.00-1.01; P = .042) on multivariable analysis. Conclusion: Myosteatosis is associated with nutritional impairment and predicts increased overall postoperative morbidity following resection for CD. Despite its association with specific increased postoperative risks, increased adiposity does not increase overall morbidity, reflecting preservation of nutritional status and relatively more quiescent disease phenotype. Impaired muscle mass and function represent an appealing target for patient optimization to improve outcomes in the surgical management of CD.


17 April 2024 in Histopathology
Verified
Journal Article
Closed access
SASusan Aherne
Susan Aherne
MDMark Donnelly
Mark Donnelly
ÉRÉanna J Ryan
Éanna J Ryan
MDMatthew G Davey
Matthew G Davey
BCBen Creavin
Ben Creavin
CScollaborators at the Centre for Colorectal Disease and International Tumour Budding Consortium funded by the Dutch Cancer Society
collaborators at the Centre for Colorectal Disease and International Tumour Budding Consortium funded by the Dutch Cancer Society

27 September 2023 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
DLDavid Lennon
David Lennon
MDMark Donnelly
Mark Donnelly
JMJohn Mahon
John Mahon
ÉRÉanna J. Ryan
Éanna J. Ryan
OROdhrán K. Ryan
Odhrán K. Ryan
SMSean Martin
Sean Martin